Xia Li | Diabetes | Best Researcher Award

Posted on by sciencefather

Prof. Xia Li | Diabetes | Best Researcher Award

Prof. Xia Li, Depart. of Metabolism & Endocrinology, Second Xiangya Hospital, Central South University, China

Dr. Xia Li is a prominent physician-scientist and academic leader in the field of endocrinology and metabolism. She serves as Professor and Director of the Department of Metabolism & Endocrinology at the Second Xiangya Hospital, Central South University. Additionally, she holds the position of Vice-director at the National Clinical Research Center for Metabolic Diseases and Vice-chairman of the China Type 1 Diabetes Alliance. Dr. Li is a prolific contributor to global diabetes research, particularly in Type 1 Diabetes (T1D), with over 100 publications in leading journals including Nature Communications, Diabetologia, and Diabetes Care. As an editor for the Journal of Clinical Endocrinology & Metabolism and Journal of the Endocrine Society, she contributes significantly to scholarly discourse. Her pioneering work includes establishing a T1D cohort in China, exploring immunological aging, and driving improvements in personalized diabetes management.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Leadership in Clinical and Research Roles

    • Director of Metabolism & Endocrinology at the prestigious Second Xiangya Hospital.

    • Vice-director of a national-level research center for metabolic diseases.

    • Vice-chairman of the China Type 1 Diabetes Alliance.

  2. High-Impact Research and Publications

    • Over 100 peer-reviewed publications in top journals like Nature Communications, Diabetologia, Diabetes Care, and Sleep Medicine.

    • Research addresses critical issues in Type 1 Diabetes (T1D), including disease progression, glycemic variability, AI applications, and long-term complications.

  3. Innovative Contributions

    • Established a national T1D follow-up cohort focused on clinical, immunological, and genetic characteristics—critical for personalized medicine.

    • Pioneered research on immunological aging in GDM offspring, indicating intergenerational effects of diabetes.

  4. Academic Service & Influence

    • Serves on the editorial boards of the Journal of Clinical Endocrinology & Metabolism and Journal of The Endocrine Society.

    • Involved in large-scale international efforts (e.g., T1D Index, IDF Atlas 2025).

  5. Interdisciplinary Expertise

    • Combines endocrinology, immunology, AI (e.g., neural Turing machines), and epidemiology to tackle diabetes holistically.

🔧 Areas for Improvement:

  1. International Recognition Expansion

    • While highly respected in China, global visibility (especially in Western institutions and conferences) could be enhanced further.

    • Publishing in more open-access and globally visible platforms may improve reach.

  2. Cross-disciplinary Collaborations

    • Further collaboration with AI labs and data science teams outside the medical field can help accelerate predictive modeling in diabetes.

  3. Translation to Policy and Practice

    • Although the research is strong, structured efforts to influence national diabetes policy or produce public health guidelines would elevate her societal impact.

🎓 Education:

Professor Xia Li earned her MD and completed her medical training in internal medicine and endocrinology from Central South University, one of China’s leading medical institutions. She later pursued advanced academic and clinical training in metabolic diseases and immunology, contributing to the global understanding of diabetes pathogenesis. With a strong foundation in clinical sciences, she combined this with extensive research exposure to endocrinology, particularly Type 1 Diabetes (T1D), autoimmune mechanisms, and metabolic complications. Her education provided her with a multidisciplinary approach, integrating genomics, immunology, and endocrinology to innovate treatment strategies and diagnostic models. Through her education, Dr. Li laid the groundwork for a career that bridges cutting-edge research and transformative clinical practice.

💼 Experience:

Dr. Xia Li has over two decades of experience in clinical endocrinology, metabolic disease research, and academic leadership. As the Director of the Department of Metabolism & Endocrinology at Second Xiangya Hospital and Vice-director of the National Clinical Research Center for Metabolic Diseases, she leads critical national-level initiatives. She also plays a key leadership role as Vice-chairman of the China Type 1 Diabetes Alliance. In research, she has been instrumental in establishing a longitudinal T1D cohort to study disease progression and remission phases. As an editorial board member for leading endocrine journals, she supports high-impact scientific publishing. Her expertise spans clinical trials, biomarker discovery, AI in metabolic diseases, and population health. With a vast international network and interdisciplinary collaborations, Dr. Li has also mentored numerous students and clinicians, reinforcing her influence in both clinical and academic endocrinology.

🔬 Research Focus:

Professor Xia Li’s research focuses primarily on Type 1 Diabetes (T1D), including its immunological, genetic, and clinical characteristics. She established a nationwide T1D follow-up cohort to explore disease remission and progression stages, offering new insights into pathophysiology. Her studies examine monocyte aging, autoimmunity, sleep’s role in glucose regulation, and the efficacy of AI and automated insulin delivery systems. She is also engaged in research on gestational diabetes’ intergenerational effects, insulin resistance, and executive dysfunction in diabetic populations. Furthermore, Dr. Li explores AI-driven prognostics and the impact of cumulative glycemic exposure. Her work aims to personalize diabetes treatment, improve early diagnosis, and prevent complications. Her integrative approach includes systems biology, time-series analysis, and national public health frameworks, positioning her as a leading investigator bridging laboratory research with real-world clinical practice.

📚 Publications Top Notes: 

  1. 🧬 Immunological age prediction of monocytes in GDM offspring – Immunity and Ageing, 2025

  2. 🛌 The effect of sleep quality on glucose variability in T1D adolescents in China – Sleep Medicine, 2025

  3. 🌍 Global T1D prevalence, incidence & mortality estimates – IDF Atlas 2025 – Diabetes Research and Clinical Practice, 2025

  4. 🧠 Executive function deficits in adults with childhood-onset T1D – Journal of Diabetes Investigation, 2025

  5. 🤖 Efficacy and safety of automated insulin delivery systems: A meta-analysis – Diabetes Metabolism Journal, 2025

  6. 🩸 HbA1c and insulin dose roles in insulin resistance-related disorders – Chinese Journal of Internal Medicine, 2025

  7. 🏥 Practice insights of the National Diabetes Prevention Center (DPCC) in Hunan – Journal of Chinese Physician, 2025

  8. 🧪 Differential diagnosis among T1DM, T2DM, and monogenic diabetes – Chinese Journal of Diabetes Mellitus, 2025

  9. 👩‍⚕️ Tribute to Prof. Wu Hanwen, pioneer of metabolism in China – Chinese Journal of Diabetes Mellitus, 2025

  10. 🧠🧮 Interpretable neural Turing machine for T2DM prognosis – International Journal of Medical Informatics, 2025

🏁 Conclusion:

Professor Xia Li is an exceptionally qualified candidate for the Best Researcher Award. Her groundbreaking work in Type 1 Diabetes, leadership roles in both clinical and research institutions, and her commitment to advancing personalized medicine through multi-center studies and AI-driven analytics, position her as a transformative figure in global endocrinology.

Entesar Hassan | Genetics | Best Researcher Award

Posted on by sciencefather

Dr. Entesar Hassan | Genetics | Best Researcher Award

Dr. Entesar Hassan, National research center, Egypt

Dr. Entesar El-Sayed Hassan Mohammed is an Assistant Professor in the Genetics and Cytology Department at the National Research Centre, Egypt. With a specialization in cytogenetics, she has dedicated her career to exploring the genotoxic impacts of environmental and industrial chemicals and evaluating the protective effects of natural and synthetic agents. Her academic path has been marked by excellence, beginning with a B.Sc. in Genetics from Al-Azhar University and culminating in a Ph.D. from Ain Shams University. She is a recognized contributor to numerous national and international conferences, and her work has been published in respected journals such as Mutation Research and Cytologia. Dr. Hassan is also an active member of several scientific organizations, including the Arab Society for Medical Research. Her ongoing projects reflect a commitment to environmental safety, genetic health, and public well-being. Her dedication makes her a strong contender for the Best Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award

  1. Specialized Expertise: Dr. Entesar has a clear research focus in cytogenetics and genotoxicology, with over 20 years of experience studying the harmful effects of industrial and environmental agents on genetic material.

  2. Robust Academic Background: She holds a Ph.D. in Genetics and has authored impactful studies on DNA damage, chromosomal aberrations, and protective agents like vitamins, selenium, and natural products.

  3. Diverse Research Portfolio: She has contributed to multidisciplinary research on:

    • Autoimmune disorders

    • Pesticide safety

    • Nanoparticles

    • Natural therapeutic agents

  4. Research Output:

    • Over 10 peer-reviewed publications, many in Scopus- and Crossref-indexed journals.

    • Notable contributions to high-impact journals such as Mutation Research, Cytologia, and Molecular Biology Reports.

  5. Collaborative and Interdisciplinary Approach: Works alongside pharmacologists, toxicologists, and biochemists in national-level projects.

  6. Scientific Engagement:

    • Regular speaker and participant in national and international conferences.

    • Active member of professional bodies such as the Arab Society for Medical Research and Association of Women in Science in Developing Countries.

  7. Applied Impact: Her studies have practical implications for public health and environmental safety, especially concerning natural compound therapies and biochemical markers of genetic damage.

⚠️ Areas for Improvement

  1. International Visibility:

    • Most research is currently Egypt- or region-centric. Increasing global collaborations or publishing in more international journals could enhance reach and citation impact.

  2. Grant Leadership:

    • Taking the lead as Principal Investigator (PI) in internationally funded projects could further demonstrate leadership.

  3. Technology Integration:

    • While bioinformatics is mentioned, deeper integration of genome-wide technologies, CRISPR-based tools, or NGS could strengthen methodological innovation.

  4. Student Mentorship Record:

    • Documenting the supervision of postgraduates or mentorship contributions could enrich her academic profile.

🎓 Education (150 words)

Dr. Entesar earned her Bachelor of Science in Genetics from Al-Azhar University in 1996, graduating with honors and distinction. She continued her postgraduate studies at the same university, obtaining a Master’s degree in Genetics in 2001. Her thesis, titled “The protective role of soybean seeds and thiola against the genotoxicity of potassium dichromate in mice”, set the foundation for her focus on environmental genotoxicity. Pursuing advanced research, she completed her Ph.D. in Science at Ain Shams University in 2005. Her doctoral research titled “Assessment of the genotoxic effect of some industrial metals and the possible protective role of vitamins and selenium”, highlighted her interest in mitigating toxic effects of environmental agents through natural and pharmaceutical interventions. This strong academic foundation has significantly contributed to her research excellence in cytogenetics and molecular toxicology.

👩‍🔬 Experience (150 words)

Dr. Entesar El-Sayed Hassan has over two decades of experience in genetic toxicology, with a primary appointment as an Assistant Professor in the Genetics and Cytology Department at Egypt’s National Research Centre. She has been instrumental in several national research projects from 2016 to 2024, including investigations on autoimmune diseases, eco-friendly pesticides, and nanoparticle applications in disease control. She participated in prestigious conferences and workshops in Egypt and Saudi Arabia, covering topics from DNA fragmentation to strategic research planning. Her research integrates cytogenetics, molecular biology, and environmental safety. Her collaborative approach is evident in multi-disciplinary publications and contributions to scientific societies such as the Arab Society for Medical Research and the Association of Women in Science in Developing Countries. Dr. Entesar’s extensive practical, academic, and collaborative experience positions her as a leader in cytogenetic research and innovation.

🔬 Research Focus (150 words)

Dr. Entesar’s research focuses on cytogenetics and genotoxicology, particularly the effects of environmental and industrial agents on genetic material. Her work evaluates DNA damage, chromosomal abnormalities, and mutagenic potential of various chemical compounds, such as potassium dichromate, vinblastine, cobalt chloride, and beryllium chloride. She also investigates the protective effects of antioxidants, including selenium, essential oils, soybean seeds, and vitamins A, C, and E. In recent years, her research has expanded to explore nanotechnology applications, such as pectin nanoparticles from citrus waste, for therapeutic use in inflammatory and metabolic disorders. Her studies combine in vivo experiments in rodents with molecular biology tools like Comet Assay and DNA fragmentation analysis. This research supports the development of eco-friendly therapeutic strategies and contributes to global knowledge on environmental safety, genetic health, and preventive toxicology. Dr. Entesar’s work is vital in developing safer alternatives for managing genotoxic exposures.

📚 Publications (Titles in Single Line Format with Emojis)

  • 🧪 The protective role of thiola against the genotoxic effect of potassium dichromate in mice in vivo – Cytologia, 2001

  • 🌱 The protective role of thiola and soybean seeds against the genotoxicity induced by potassium dichromate in mice – Mutation Research, 2002

  • 🐭 Clastogenic effects of the fasciolicides closantel and nitroxynil on mice somatic and germ cells – Cytologia, 2007

  • 🧬 Antimutagenic effect of selenium and vitamins against the genotoxicity induced by cobalt chloride in mice – Cytologia, 2006

  • ⚗️ Studies on the genotoxic effect of beryllium chloride and the possible protective role of selenium/vitamins A, C and E – Mutation Research, 2008

  • 🍋 Cymbopogon citratus essential oil has hepato/renal protection and anti-genotoxicity against carbon tetrachloride – Comunicata Scientiae, 2020

  • 🧫 Genotoxicity, DNA damage and sperm defects induced by vinblastine – Molecular Biology Reports, 2023

  • 🔬 Fennel (Foeniculum vulgare) essential oil ameliorates DNA and histopathological damage induced by cyclophosphamide in mice – Bioscience Research, 2019

🧾 Conclusion

Dr. Entesar El-Sayed Hassan Mohammed presents a strong and consistent research record with significant contributions to cytogenetics, environmental genotoxicology, and natural compound therapeutics. Her dedication to applied research, active scientific participation, and interdisciplinary projects make her a worthy and commendable candidate for the Best Researcher Award.

Danyelle Townsend | Molecular Mechanisms Signaling | Women Researcher Award

Posted on by sciencefather

Dr. Danyelle Townsend | Molecular Mechanisms Signaling | Women Researcher Award

 

Dr. Danyelle Townsend | Medical University of South Carolina | United States

Dr. Danyelle M. Townsend is a leading biomedical scientist specializing in redox biology, cancer pharmacology, and cellular response to oxidative stress. Based at the Medical University of South Carolina (MUSC), she has over two decades of experience in cancer research and drug development. Dr. Townsend has co-authored numerous high-impact publications and has been consistently recognized among the top 2% of cited scientists globally in biology and biochemistry by Research.com. She is especially noted for her mentorship, guiding undergraduate and postgraduate researchers, particularly through DoD-supported programs for Historically Black Colleges and Universities (HBCUs). Dr. Townsend’s collaborative research focuses on glutathione-related enzymes, redox-sensitive signaling, and drug resistance in cancers such as prostate and breast. Her innovative patents target protein disulfide isomerase and oxidative stress biomarkers. Through her research, mentorship, and leadership, Dr. Townsend exemplifies excellence in scientific discovery and training of future biomedical researchers.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Prolific Research Career: Dr. Townsend has a sustained, high-impact career in redox biology, cancer pharmacology, and oxidative stress signaling—critical and emerging areas in biomedical science.

  2. Global Recognition: She has been named among the top 2% of cited scientists internationally in biology and biochemistry for four consecutive years (2021–2024) by Research.com, demonstrating enduring influence in her field.

  3. Mentorship Excellence: Dr. Townsend has received multiple Department of Defense Mentorship Awards, particularly for her support of underrepresented students in the HBCU Summer Prostate Cancer Training Programs, highlighting her commitment to inclusive science education.

  4. Innovative Contributions: She holds pending patents on novel therapeutics and redox biomarkers, reflecting her ability to translate basic science into practical clinical tools.

  5. Scholarly Output: With an h-index of 56 and hundreds of citations on core publications, her work is widely acknowledged and foundational to the understanding of redox pathways and drug resistance mechanisms.

  6. Leadership and Collaboration: Dr. Townsend co-edited Redox Pathways in Cancer and authored multiple book chapters and peer-reviewed articles, often in interdisciplinary and collaborative contexts.

🛠️ Areas for Improvement or Consideration:

  1. Visibility in International Forums: While her citation metrics are exceptional, more evidence of plenary talks or keynote presentations at global scientific congresses could strengthen her profile for a competitive international award.

  2. Formal Educational Background: Her academic degrees, institutions attended, and timeline of academic progression are not explicitly listed. Including this would further validate her qualifications in formal review processes.

  3. Leadership Titles: More information about formal academic or institutional leadership roles (e.g., Director, Chair, PI of center grants) would demonstrate a broader leadership footprint.

  4. Diversity in Publication Authorship: While many of her key papers are co-authored with a strong, consistent team, highlighting leadership in multidisciplinary, international collaborations could bolster the perception of broader influence.

🎓 Education:

While specific degree and institution details were not provided, Dr. Danyelle M. Townsend is affiliated with the Medical University of South Carolina (MUSC), where she has played a pivotal role in cancer biology and pharmacology research. Her career indicates a strong academic foundation likely rooted in biomedical sciences, cellular biology, and molecular pharmacology. Dr. Townsend’s educational background likely includes a Ph.D. in a related field, based on her authorship position and editorial roles. Her scholarly rigor is reflected in her leadership of NIH and DoD-funded research programs and mentorship of students from HBCUs. She also co-edited the book Redox Pathways in Cancer and has authored chapters in major scientific handbooks, further reflecting her expertise and advanced training. Her scientific acumen and consistent output in high-impact journals underscore the depth and breadth of her education in biomedical research and her commitment to fostering the next generation of scientists.

💼 Experience:

Dr. Townsend has extensive professional experience in biomedical research, primarily at the Medical University of South Carolina (MUSC). Her expertise spans redox regulation, oxidative stress, glutathione biology, and anticancer therapeutics. Over the years, she has contributed as a principal investigator, mentor, and editor, co-developing novel therapeutic strategies targeting redox systems in cancer. She has served as a mentor for multiple Department of Defense-funded undergraduate and HBCU summer research programs, earning several mentorship excellence awards. Her work includes editorial contributions to high-impact cancer research books and journals. She holds pending patents on small molecule inhibitors and plasma protein biomarkers related to reactive oxygen and nitrogen species (ROS/RNS). Her consistent citation record and scientific productivity have placed her among the top 2% of cited biology and biochemistry scientists globally for four consecutive years. Dr. Townsend’s dynamic and multifaceted career reflects her leadership in translational cancer research and scientific mentorship.

🏅 Awards and Honors:

Dr. Danyelle M. Townsend has been widely recognized for her excellence in mentorship and scientific research. Between 2009 and 2014, she received consecutive mentorship awards from the U.S. Department of Defense for her role in guiding students in the HBCU Collaborative Summer Prostate Cancer Training Programs at MUSC. In 2015, she was honored with the Power of a Mentor Award by Charleston County Academic Magnet High School. Her scientific achievements have also earned global recognition; from 2021 through 2024, she has been ranked among the top 2% of most-cited researchers internationally in biology and biochemistry by Research.com. These accolades underscore her commitment not only to groundbreaking research but also to the development of young scientists, particularly from underrepresented communities. In addition, she is listed as an inventor on patents related to protein disulfide isomerase inhibitors and biomarkers for oxidative stress, further reflecting her innovation in redox-targeted therapies.

🔬 Research Focus:

Dr. Townsend’s research centers on redox regulation in cancer biology, particularly focusing on glutathione S-transferases (GSTs), protein disulfide isomerases, and oxidative stress signaling. Her work has advanced understanding of how redox imbalances contribute to drug resistance and tumor progression, providing insight into new therapeutic avenues. She investigates redox-sensitive proteins and their role in cellular detoxification, stress responses, and ferroptosis. In collaboration with Dr. Kenneth D. Tew and others, she has co-authored key publications and book chapters that explore the dual roles of antioxidant enzymes in cancer. Her research also includes drug development efforts targeting redox pathways and exploring plasma biomarkers for exposure to reactive oxygen and nitrogen species. Through preclinical and translational studies, Dr. Townsend’s work aims to develop targeted therapies and diagnostic tools for cancers, especially prostate and breast. Her impact is evident through numerous citations, prestigious awards, and mentorship of future biomedical scientists.

📚 Publications Top Notes:

  1. 📄 The Multifaceted Role of Glutathione S-Transferases in Health and Disease – Biomolecules (2023)

  2. 📄 Microsomal glutathione transferase 1 in cancer and regulation of ferroptosis – Adv Cancer Res (2023)

  3. 📄 Protein disulfide isomerase family-mediated redox regulation in cancer – Adv Cancer Res (2023)

  4. 💊 Acute toxicity and antitumor activity of novel doxorubicin liposomes – Biomed Pharmacother (2023)

  5. 💊 Alpha-tocopheryl succinate and doxorubicin-loaded liposomes in breast tumor model – Biomed Pharmacother (2023)

  6. 🔬 Adaptive changes in tumor cells in response to reductive stress – Biochem Pharmacol (2023)

  7. ⚗️ Synergism of VDAC-targeting small molecules in hepatocarcinoma – TBD (2023)

  8. 🧪 The importance of glutathione in human disease – Biomed Pharmacother (2003)

  9. 🧪 Role of glutathione-S-transferase in anti-cancer drug resistance – Oncogene (2003)

  10. 🧪 The antioxidant role of selenium and seleno-compounds – Biomed Pharmacother (2003)

  11. 🧪 Carotenoids in prevention of human pathologies – Biomed Pharmacother (2004)

  12. 🧬 GST polymorphisms: cancer incidence and therapy – Oncogene (2006)

  13. 🧫 Cisplatin metabolism to nephrotoxin in tubule cells – JASN (2003)

  14. 🧬 Causes and consequences of cysteine S-glutathionylation – JBC (2013)

  15. 🧬 S-glutathionylation: from molecular mechanisms to health outcomes – Antioxid Redox Signal (2011)

🏁 Conclusion:

Dr. Danyelle M. Townsend is highly suitable for the Research for Women Researcher Award. Her influential scholarship, sustained productivity, and extraordinary mentorship record—particularly in promoting diversity in science—make her a standout nominee. Her work addresses global health challenges (e.g., prostate and breast cancer) through novel redox-targeted strategies, making a significant impact in both academic and translational research domains. With minor enhancements in visibility and leadership documentation, her candidacy would be even more compelling.

Frédérique Pasquali | Microbial Cell Biology | Women Researcher Award

Posted on by sciencefather

Dr. Frédérique Pasquali | Microbial Cell Biology | Women Researcher Award

Dr. Frédérique Pasquali | Alma Mater Studiorum – University of Bologna | Italy

Dr. Frédérique Pasquali is a Junior Assistant Professor at the Alma Mater Studiorum – University of Bologna. She is an expert in microbial food safety and molecular microbiology, with a focus on the genetic and environmental dynamics of foodborne pathogens. Her research integrates metagenomics, antimicrobial resistance monitoring, and source attribution modeling to advance microbial traceability and public health surveillance. She has made notable contributions through high-impact publications and interdisciplinary collaborations with international institutions and organizations, including EFSA. Dr. Pasquali is known for her leadership within academic programs, particularly in food risk management, and her active involvement in European scientific panels. Her career reflects a commitment to scientific excellence and the promotion of food safety in both research and policy settings.

Publication profile:

scopus

 🌟Strengths for the Award :

  • Outstanding Research Portfolio: Dr. Pasquali has an impressive publication record in high-impact journals such as Nature Communications, Scientific Reports, and Frontiers in Microbiology, showcasing deep expertise in microbial genomics, antimicrobial resistance, and source attribution.

  • Relevance and Innovation: Her recent work on sewage metagenomics offers innovative tools for source-attributed surveillance—a timely and impactful contribution to public health and environmental monitoring.

  • Leadership & Academic Involvement: As a Vice-representative of a master’s program in food risk management, she demonstrates strong educational leadership. Her selection to the EFSA reserve list of experts further emphasizes her scientific authority at the European level.

  • Collaborative and Interdisciplinary Work: Active in international consortia and multidisciplinary studies, she bridges the gap between microbial science, risk management, and policy implementation.

  • Recognition & Achievements: Her best poster award at the 34th EAEVE conference and national habilitation for associate professor signify peer recognition and potential for academic advancement.

🔧Areas for Improvement :

  • Visibility as Principal Investigator: While she contributes significantly to consortium papers, increased PI-level leadership in grants and first/last authorships could further solidify her independence as a researcher.

  • Mentorship Documentation: While involved in education, more formal documentation or evidence of mentoring early-career researchers, especially women in STEM, would strengthen her nomination for a gender-focused award.

  • Policy Impact Metrics: While aligned with EFSA, showcasing more direct outcomes or influence on policy would highlight broader societal impacts of her work.

🎓 Education:

Dr. Pasquali earned her Bachelor of Science in Biology in March 2000 from the University of Bologna, where she continued her studies to complete a PhD in Molecular Microbiology in April 2005. Her doctoral work laid the foundation for her expertise in bacterial genomics and microbial ecology. Following her PhD, she pursued postdoctoral research in microbial foodborne traceability, finishing in September 2009. Her academic journey has been deeply rooted in the University of Bologna, one of Europe’s most historic institutions, where she developed a robust understanding of microbial interactions, food safety, and biotechnology. Throughout her education, she engaged in interdisciplinary work that combined microbiology, bioinformatics, and public health. Her academic credentials reflect a long-standing dedication to research and a commitment to solving real-world challenges in food microbiology and safety.

🧪 Experience:

Dr. Pasquali currently serves as Junior Assistant Professor at the University of Bologna, where she plays a key role in teaching and research. Since 2025, she has been Vice-Representative of the Curriculum of Risk Management in the Master’s program in Food Safety and Food Risk Management. Her professional experience spans more than 20 years, including extensive work on microbial source attribution, antimicrobial resistance, and metagenomics. She has collaborated on several European-level research initiatives and actively contributes to EFSA panels and committees. Her previous roles include postdoctoral research in microbial traceability, contributing to national and international food safety surveillance strategies. Her work bridges science and policy, enabling data-driven decision-making in food safety. She also plays an active mentorship role, fostering the next generation of microbiologists. Her combination of teaching, research, and policy advisory experience positions her as a respected leader in her field.

🏆 Awards and Honors:

Dr. Frédérique Pasquali has been recognized with multiple awards and honors throughout her career. In 2021, she received the Best Poster Award at the 34th European Association of Establishments for Veterinary Education (EAEVE) conference held at the University of Turin. In 2017, she obtained the National Scientific Qualification for Associate Professor (07/H2 – SSD MVET02/B) in Italy, marking her academic excellence and eligibility for advanced faculty positions. In 2023, she was listed in the EFSA/E/2023/01 reserve pool for experts eligible to serve on EFSA Scientific Panels and the Scientific Committee. As of 2024, she continues to serve on the EFSA reserve list, reinforcing her status as a recognized authority in food safety and risk analysis. These accolades reflect her continued dedication to high-quality research and public health protection through science-based risk management.

🔬 Research Focus:

Dr. Pasquali’s research focuses on the microbial ecology and genomics of foodborne pathogens, with a special interest in antimicrobial resistance and microbial traceability. She utilizes metagenomic time-series analysis to distinguish environmental, human, and seasonal microbial profiles, aiding in accurate source attribution. Her work contributes to developing early-warning systems for foodborne outbreaks by integrating big data with network modeling. She is particularly interested in the genomic evolution of pathogens like Salmonella Typhimurium and Klebsiella, including their resistomes and persistence in food processing environments. Her contributions to One Health approaches link microbial data with public health and environmental surveillance. She actively collaborates with EFSA and international research teams to bridge gaps between research and policy, aiming to improve food safety, antimicrobial stewardship, and surveillance methodologies.

📚 Publication Titles Top Notes:

  1. 🧫 Time-series sewage metagenomics distinguishes seasonal, human-derived and environmental microbial communities potentially allowing source-attributed surveillance (Nat Commun, 2024)

  2. 🧬 Genomic features of Klebsiella isolates from artisanal ready-to-eat food production facilities (Sci Rep, 2023)

  3. 🐔 The resistome of commensal Escherichia coli isolated from broiler carcasses “produced without the use of antibiotics” (Poultry Science, 2022)

  4. 🦠 The spatiotemporal dynamics and microevolution events that favored the success of the highly clonal multidrug-resistant monophasic Salmonella Typhimurium circulating in Europe (Front Microbiol, 2021)

  5. 🕸 Network Approach to Source Attribution of Salmonella enterica Serovar Typhimurium and Its Monophasic Variant (Front Microbiol, 2020)

✅Conclusion :

Dr. Frédérique Pasquali is a highly suitable candidate for the Research for Women Researcher Award. Her work is scientifically rigorous, socially relevant, and internationally recognized. She embodies the spirit of this award through her contributions to food safety, her role in shaping future professionals, and her presence in European scientific governance. With continued support and visibility, she is poised to make even greater contributions to science and public health.

 

Fani Pantouli | Immunology Cellular Interactions | Best Researcher Award

Posted on by sciencefather

Dr. Fani Pantouli | Immunology Cellular Interactions | Best Researcher Award

Dr. Fani Pantouli, Cleveland Clinic Florida Research and Innovation Center, United States

Dr. Fani Pantouli is a passionate and results-driven research scientist with deep expertise in neuroscience, pharmacology, immunology, and oncology. A USA permanent resident, she currently serves as a Postdoctoral Fellow at the Cleveland Clinic Florida Research and Innovation Center. Her work bridges cutting-edge vaccine development and cancer therapeutics, contributing significantly to preclinical and translational research. Dr. Pantouli’s scientific approach blends in vivo and in vitro techniques to uncover therapeutic pathways, particularly in head and neck cancer and viral immunology. Her interdisciplinary knowledge is reflected in a growing portfolio of peer-reviewed publications addressing pressing biomedical challenges, from COVID-19 immunity to neuropsychiatric disorders. She is known for her innovative methodologies, collaborative mindset, and unwavering dedication to advancing human health. Dr. Pantouli’s work is making a meaningful impact on personalized medicine and translational therapeutics, positioning her as a rising leader in biomedical research.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Multidisciplinary Expertise
    Dr. Pantouli integrates neuroscience, immunology, pharmacology, and oncology into her research, making her contributions uniquely cross-disciplinary and impactful.

  2. High-Impact Research in Vaccine Development
    Her postdoctoral work on COVID-19 and respiratory viruses, particularly her development of T-cell profiling and viral neutralization assays, directly informs global efforts in personalized vaccine design.

  3. Innovative Cancer Models
    She developed a novel in vivo murine model for head and neck squamous cell carcinoma, advancing drug screening for p53-related targets. This is vital in understanding and treating cancers with p53 mutations.

  4. Robust Publication Record
    Dr. Pantouli has authored or co-authored multiple peer-reviewed articles in reputable journals (e.g., Vaccines, Neuropsychopharmacology), with several under review in top-tier outlets like Science and Journal of Biological Psychiatry.

  5. Focus on Health Equity
    Her research into ethnic differences in immune response underscores a strong commitment to inclusive and equitable healthcare.

  6. Experience in Preclinical & Translational Research
    Her hands-on experience building disease models and testing therapeutic strategies bridges basic science and clinical application—core to translational medicine.

⚠️ Areas for Improvement:

  1. Independent Research Leadership
    While she has made significant contributions as a postdoctoral fellow, moving toward independent investigator roles (e.g., PI on grants) would strengthen her candidacy.

  2. Visibility and Recognition
    Increased presence in international symposia, keynote talks, or award recognitions would help boost her visibility within the scientific community.

  3. Mentorship and Community Involvement
    Involvement in mentoring junior researchers or leading educational outreach initiatives could further showcase her leadership potential.

🎓 Education:

Dr. Pantouli holds a Ph.D. in Neuropharmacology from the University of Surrey and St. George’s University of London, awarded between 2014 and 2017. Her doctoral studies explored neural mechanisms underpinning pharmacological and behavioral outcomes, laying a solid foundation for her current work in translational medicine. Prior to her Ph.D., she completed an MSc in Molecular Neuroscience from the University of Bristol in 2011, where she specialized in neurodevelopmental and degenerative disorders. Her undergraduate studies were completed at the University of Bedfordshire in 2010, where she earned a BSc (Hons) in Biomedical Science. Dr. Pantouli’s academic trajectory reflects a commitment to interdisciplinary learning and a focus on brain and immune system interactions. Her education combines rigorous training in molecular biology, pharmacology, and neuroscience, empowering her to address complex biomedical questions with a systems-level perspective.

🧪 Experience:

Dr. Pantouli is currently a Postdoctoral Fellow in Vaccine Development Research at the Cleveland Clinic Florida Research and Innovation Center (June 2023 – Present), where she investigates T cell immune responses and develops viral neutralization assays for respiratory viruses including SARS-CoV-2. Previously, she was a Postdoctoral Fellow in the Cancer Research Lab at the same institute (January 2022 – June 2023), where she created innovative murine models of head and neck cancer to evaluate therapeutic efficacy targeting mutant p53. Her research integrates advanced in vivo systems and immune profiling to enhance drug discovery and vaccine evaluation. With a decade-long track record across academia and clinical research centers, Dr. Pantouli has developed robust platforms for translational research, immunotherapeutics, and precision medicine. Her skills span experimental design, animal modeling, immunoassays, and bioanalysis, equipping her to tackle critical gaps in infectious disease and oncology treatment strategies.

🔬 Research Focus:

Dr. Pantouli’s research is centered on translational medicine, focusing on vaccine development, immunotherapy, and molecular pharmacology. Her current projects address immune modulation in viral infections, especially COVID-19, and the development of preclinical assays for vaccine and drug evaluation. She also leads research in oncology, particularly targeting p53 mutations in head and neck squamous cell carcinoma using in vivo models. Her earlier academic work examined the neural and behavioral effects of neuropeptides and receptor modulators in models of autism and Fragile X Syndrome, showing a consistent interest in neuroimmune interactions. She employs a multidisciplinary approach—blending pharmacological, molecular, and immunological tools—to explore how targeted therapies can be optimized for diverse populations. Her work is vital for advancing personalized medicine, especially for aging populations and ethnically diverse cohorts, where vaccine efficacy and immune response can differ significantly.

📚 Publications Top Notes:

  • 🧫 Ethnic differences in COVID-19 T cell immunity responses across variants from Wuhan to Omicron – Accepted in Vaccines

  • 🧠 Evaluation of SR-17018 and oxycodone in the conditioned place preference paradigm using peanut butter chip vehicle – In preparation, Neuropharmacology

  • 🧬 Generation of antigen-specific paired heavy-light chain antibody sequences using large language models – Submitted to Science

  • 💉 COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly – Vaccines (2025)

  • 🧩 Tilted striatofugal balance and mGluR4 modulation in the Fmr1 mouse model of Fragile X Syndrome – Under review, Journal of Biological Psychiatry

  • 👃 Acute, chronic and conditioned effects of intranasal oxytocin in mu opioid receptor knockout mice: social context matters – Neuropsychopharmacology (2024)

🧾 Conclusion:

Dr. Fani Pantouli is a highly promising and impactful scientist whose research spans some of the most critical health challenges of our time—infectious diseases, cancer, and neurodevelopmental disorders. Her technical expertise, innovative model development, and deep understanding of immune and neural systems make her an excellent nominee for the Best Researcher Award.

Nives Jonjić | Cancer Cell Biology | Women Researcher Award

Posted on by sciencefather

Prof. Dr. Nives Jonjić | Cancer Cell Biology | Women Researcher Award

Prof. Dr. Nives Jonjić | Department of Pathology and Citology, CHC Rijeka | Croatia

Prof. Nives Jonjić, MD, is a Full Professor Emeritus at the Department of General Pathology and Pathological Anatomy, Faculty of Medicine, University of Rijeka, Croatia. With a distinguished academic and clinical career spanning decades, Prof. Jonjić has made significant contributions to oncologic and molecular pathology. Her work focuses on understanding molecular markers in tumor progression and their diagnostic and prognostic relevance. As a prolific researcher and author, she has published extensively in high-impact international journals and collaborated with leading experts in pathology and oncology. Known for her diagnostic precision and dedication to academic mentorship, she has guided numerous medical students, residents, and doctoral candidates. Her legacy includes groundbreaking studies on biomarkers like Nectin-2 and Nectin-4 and rare pathologic entities. Prof. Jonjić’s leadership and scientific rigor make her a prominent figure in Croatian medical science and a respected name in international pathology circles.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Academic and Clinical Experience
    Prof. Nives Jonjić is a Full Professor Emeritus in pathology with decades of clinical, academic, and research experience, making her a veteran in her field.

  2. Strong Research Track Record

    • Multiple first and co-authored papers in peer-reviewed journals such as Current Issues in Molecular Biology, Pathology Research and Practice, and Clinical Pathology.

    • A clear focus on oncologic pathology, including biomarkers (e.g., Nectin-2 and Nectin-4), angiogenesis, lymphomas, and myelomas.

  3. Mentorship and Academic Leadership
    She has played a key role in mentoring junior scientists, guiding doctoral research, and shaping curriculum and teaching in pathology at the University of Rijeka.

  4. Work on Rare and Challenging Diagnoses
    Her research includes diagnostic dilemmas and rare malignancies, showing depth and clinical relevance, such as CD20-negative B-cell lymphomas and extranodal Hodgkin lymphomas.

  5. Contribution to Women in Science
    As a senior female figure in medicine, her position as a full professor and mentor has made her a role model in advancing women’s participation in scientific leadership roles.

📉 Areas for Improvement:

  1. Broader International Visibility
    While her research is of high quality, greater engagement in global collaborative projects, EU-funded consortia, or as a keynote speaker in international forums could enhance her visibility outside Croatia.

  2. Higher Citation Metrics and Impact Index
    Although several of her publications are impactful, a few are recent and not yet widely cited. Participation in meta-analyses or review articles might help amplify her citation footprint.

  3. Digital and Social Research Presence
    A more proactive presence on platforms like ResearchGate, ORCID, or Google Scholar and involvement in open-access science movements could increase accessibility to her work.

🎓 Education:

Prof. Nives Jonjić completed her Medical Degree (MD) at the Faculty of Medicine, University of Rijeka, where she also pursued her postgraduate education and specialization in pathology. Her academic excellence was evident early in her medical training, leading to her progression into research and teaching. She earned her doctoral degree (PhD) with a focus on tumor biology and pathology. Over the years, she attended various advanced courses and workshops in Europe related to histopathology, immunohistochemistry, and oncologic diagnostics. Her commitment to continuous learning kept her updated with evolving trends in cancer research and molecular pathology. Through rigorous training and international collaborations, she established herself as a scholar deeply engaged with both clinical and experimental pathology. Her educational path reflects a deep integration of medical knowledge, critical inquiry, and a lifelong dedication to academic excellence.

🧪 Professional Experience:

Prof. Nives Jonjić has over 35 years of experience in academic medicine and pathology. Beginning as a junior lecturer and advancing through roles of Associate Professor and Full Professor, she served at the Faculty of Medicine, University of Rijeka, where she also led the Department of General Pathology and Pathological Anatomy. Her clinical practice included diagnostic histopathology with subspecialty interests in hematopathology, soft tissue tumors, and gynecologic oncology. She played a key role in curriculum development, faculty mentorship, and postgraduate training. As an expert pathologist, she consulted on complex diagnostic cases nationally and internationally. Beyond clinical and teaching roles, she has been a principal investigator and co-investigator in multiple research projects and has evaluated numerous PhD theses. Her rich experience spans clinical excellence, research leadership, and educational mentorship, making her a pillar in Croatian medical academia.

🏆 Awards and Honors:

Prof. Nives Jonjić has received numerous awards and accolades throughout her career for her contributions to medical research, education, and clinical pathology. Among her honors are institutional recognition for excellence in teaching from the University of Rijeka, national awards for research contributions, and commendations from Croatian medical societies. She has also been invited to deliver keynote lectures at international conferences and served as a peer reviewer for esteemed pathology journals. Her election as Full Professor Emeritus reflects the high regard in which she is held by her peers and institution. Prof. Jonjić has been actively involved in academic boards and ethical committees and received acknowledgments for advancing women’s leadership in medicine. Her work continues to inspire future generations of medical researchers and clinicians, and her accolades affirm her dedication to science, education, and healthcare.

🔬 Research Focus:

Prof. Jonjić’s research primarily focuses on tumor pathology, with special emphasis on the expression and role of molecular biomarkers such as Nectin-2, Nectin-4, osteopontin, and NF-κB in cancer progression, diagnosis, and prognosis. Her studies span various malignancies including squamous cell carcinomas, glial tumors, lymphomas, and multiple myeloma. She is also engaged in investigating rare and diagnostically challenging pathological conditions, contributing to more accurate clinical-pathologic correlations. Her recent research has emphasized angiogenesis, immune profiling, and the tumor microenvironment. She employs advanced histopathological and immunohistochemical techniques to support translational applications in pathology. Through collaboration with multidisciplinary teams, her work bridges laboratory findings with clinical decision-making. Her research is widely cited, reflecting its importance in improving diagnostic accuracy and treatment stratification in oncology. Prof. Jonjić’s academic leadership and focus on innovative diagnostic markers make her a central figure in Croatian cancer research.

📚 Publications Top Notes:

  1. 🗣️ Laryngeal Squamous Cell Carcinoma Is Characterized by a Stronger Expression of Nectin-4 Compared to Nectin-2

  2. 🧠 The Prognostic Significance of Nectin-2 and Nectin-4 Expression in Glial Tumors

  3. 💉 Anti-angiogenic Effect of Bortezomib Treatment in Multiple Myeloma Associated with Lower NF-κB and OPN Expression

  4. 🔬 Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual IgK and TCR Gene Rearrangement

  5. 🦴 Angiogenesis and Osteopontin Expression in Paraskeletal Myeloma With Plasmablastic Morphology

  6. 🧪 Diagnostic Challenge of Soft Tissue Extranodal Hodgkin Lymphoma in Core-Needle Biopsy

  7. 💊 Lichen Planus Pigmentosus-like Reaction to Pirfenidone in Idiopathic Pulmonary Fibrosis

  8. 🦷 Recurrent Adamantinoma With Fibrous Dysplasia-like Feature

  9. 💉 Adalimumab as a Risk Factor for Development of Melanocytic Lesions

  10. 🧬 Expression Profiles of Metallothionein-I/II and Megalin/LRP-2 in Uterine Cervical Lesions

🏁 Conclusion:

Prof. Nives Jonjić is a highly suitable candidate for the Research for Women Researcher Award. Her scholarly contributions in pathology, especially tumor diagnostics and molecular markers, are significant and clinically relevant. Her work is anchored in academic integrity and mentorship, fostering the next generation of medical scientists. While global visibility could be enhanced, her regional impact, sustained productivity, and role as a senior academic make her a strong and deserving nominee.

 

Xiaoyan Wang | Immunology Cellular Interactions | Best Paper Award

Posted on by sciencefather

Ms. Xiaoyan Wang | Immunology Cellular Interactions | Best Paper Award

Ms. Xiaoyan Wang | Fudan University | China

Dr. Xiaoyan Wang is a dedicated cardiologist and postdoctoral fellow at Fudan University with a strong background in both clinical practice and cardiovascular research. With over a decade of academic training and medical experience, she has built expertise in ventricular remodeling, percutaneous coronary interventions, and immune responses in heart diseases. Under the mentorship of esteemed scholars such as Dr. Yunzeng Zou and Academician Yaling Han, she has published extensively in high-impact journals, reflecting her commitment to scientific advancement. Dr. Wang is currently a scholar in Harvard Medical School’s Global Clinical Scholars Research Training program and also serves as a section editor for the AME Clinical Trials Review. She actively contributes to academic communities, notably by organizing the “Excellent Academic Research Communication Club.” Her work bridges translational medicine and clinical application, aiming to improve cardiovascular patient outcomes through innovative, evidence-based approaches.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Outstanding Academic Credentials: Dr. Wang has earned her PhD from the prestigious Fudan University and is currently in the Harvard Medical School’s Global Clinical Scholars Research Training Program, signaling a top-tier academic and global research profile.

  2. Dual Research Strength in Basic and Clinical Sciences: She demonstrates an exceptional ability to bridge molecular mechanisms (e.g., immune pathways, cGAS-STING, miRNAs, circular RNAs) with clinical relevance (e.g., myocardial infarction prognosis, anemia impact in PCI), making her work highly translational.

  3. High-Impact Publications: First-author or co-first-author in peer-reviewed journals such as Signal Transduction and Targeted Therapy, Angiology, and Frontiers in Cardiovascular Medicine, with publications tackling cutting-edge cardiovascular topics.

  4. Collaborative and Interdisciplinary Focus: Contributions across institutions and disciplines—partnering with bioinformaticians, clinicians, and molecular scientists—demonstrate strong collaboration skills.

  5. Recognition & Editorial Role: Multiple awards (CPSF Fellowship, Super Postdoc at Fudan) and an editorial position at AME Clinical Trials Review show leadership and peer acknowledgment.

🛠️ Areas for Improvement:

  1. More First-Author Lead on Recent Papers: Although she holds strong co-first authorships and collaborative contributions, maintaining or increasing sole first-author outputs on impactful papers would further strengthen individual scholarly identity.

  2. Increased International Conference Visibility: While she has presented at JCS, continued or expanded visibility in global cardiovascular congresses (e.g., AHA, ESC, ACC) would enhance recognition.

  3. Grant Leadership: Future grant applications as a principal investigator (rather than team member) could affirm her leadership in project design and execution.

🎓 Education :

Dr. Xiaoyan Wang holds a Ph.D. from Fudan University’s Zhongshan Hospital (2016–2019), where she conducted fundamental research on ventricular remodeling under Dr. Yunzeng Zou’s mentorship, supported by prestigious national fellowships. She earned her Master’s degree from Dalian Medical University (2013–2016), focusing on clinical research in percutaneous coronary intervention, under Academician Yaling Han. Her academic foundation was laid with a Bachelor’s degree in Medicine from Fujian Medical University (2007–2012). Currently, she is advancing her research and clinical skills in the prestigious Global Clinical Scholars Research Training Program at Harvard Medical School (2024–2025), blending in-person and online modules. Her multi-tiered education reflects a deep integration of basic science, translational medicine, and clinical practice in cardiovascular health, equipping her to lead high-impact research and patient care initiatives.

💼 Experience:

Dr. Wang is currently a Postdoctoral Fellow at Fudan University (since 09/2023), working under Prof. Yunzeng Zou. She is also the organizer of the Excellent Academic Research Communication Club, promoting interdisciplinary dialogue. From 07/2022 to 07/2023, she served as a cardiologist at Shanghai Jiaotong University’s Ruijin Hospital, and from 2019 to 2022, as a resident in internal medicine at Zhongshan Hospital. In 2024, she began contributing as a section editor for AME Clinical Trials Review, enhancing the quality and visibility of clinical trial research. Her experience spans clinical cardiology, postdoctoral research, editorial responsibilities, and academic leadership. These roles have solidified her ability to translate scientific knowledge into medical practice, particularly in the cardiovascular field.

🏆 Awards & Honors:

Dr. Wang has received numerous accolades recognizing her academic excellence and research impact. In 2023, she was awarded both the Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation (CPSF) and the prestigious Super Postdoctoral Fellowship of Fudan University, underscoring her leadership in postdoctoral research. Her communication and writing skills were acknowledged with the Third Prize in the 8th “Buchang Cup” Young Physician Essay Contest (2019). She also presented Late Breaking Cohort Studies at the Japanese Circulation Society (JCS) Annual Meeting 2019, reflecting international recognition of her scientific contributions. These honors reflect her potential as a rising leader in cardiovascular medicine and support her suitability for the Best Paper Award.

🔬 Research Focus :

Dr. Wang’s research focuses on cardiovascular disease mechanisms, particularly immune system regulation, ventricular remodeling, and the molecular basis of heart failure. Her Ph.D. and postdoctoral studies have addressed the cGAS-STING pathway, miRNA biomarkers, circular RNAs, and inflammation-related signaling in cardiovascular dysfunction. She has also explored clinical prognostic models, such as CHA2DS2-VASc scoring, and interventions including left atrial appendage occlusion and shock wave therapy for ischemic cardiomyopathy. Her dual interest in basic science and clinical outcomes allows her to design translational research that bridges laboratory findings and therapeutic advancements. With a strong publication record and ongoing involvement in global research training at Harvard Medical School, her work aims to inform precision medicine strategies in cardiology.

📚 Publication Titles Top Notes:

  1. 🧠 The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications

  2. 🔗 The connection of immune response and cGAS-STING pathway in cardiovascular disease

  3. 🐭 Left ventricular response in hypertrophy-to-failure transition: roles of Akt, β-arrestin-2, and CaMKII

  4. 💉 Circulating miRNAs in hypertension: diagnostic value and bioinformatics analysis

  5. 🧪 Galectin-3 inhibition improves endothelial progenitor function via autophagy suppression

  6. 🔄 Circular RNA in cardiovascular disease

📌 Conclusion:

Dr. Xiaoyan Wang is highly suitable for the Research for Best Paper Award. Her profile reflects a rare and valuable integration of basic cardiovascular science and clinical innovation, with high-impact, well-cited publications and ongoing international training. Her trajectory, marked by excellence, discipline, and collaborative leadership, meets and exceeds the criteria for this award.

Tamara Braut | Cancer Cell Biology | Innovative Research Award

Posted on by sciencefather

Prof. Dr. Tamara Braut | Cancer Cell Biology | Innovative Research Award

Prof. Dr. Tamara Braut | Faculty of Medicine, University of Rijeka/ENT Clinic, Clinical hospital centre Rijeka | Croatia

Professor Tamara Braut, MD, is a renowned Croatian otorhinolaryngologist and Full Professor at the Faculty of Medicine, University of Rijeka. She serves as the Head of the Department of Otorhinolaryngology and Head and Neck Surgery. Her clinical expertise and academic leadership have significantly contributed to advancements in the diagnosis and treatment of head and neck cancers, particularly laryngeal carcinoma. With over two decades of experience, Dr. Braut is widely recognized for her work in molecular oncology, HPV-associated head and neck tumors, and translational medicine. A frequent collaborator on interdisciplinary and international projects, she is committed to personalized medicine and innovative approaches in clinical research. Her impressive portfolio of peer-reviewed publications, including case studies, multicenter analyses, and biomarker-based diagnostics, highlights her dedication to evidence-based practice and academic excellence. Professor Braut’s academic leadership and clinical insight place her among the top contributors in her specialty within Croatia and internationally.

Publication Profile:

Google Scholar

Strengths For Award:

  • Pioneering work in head and neck oncology and molecular diagnostics

  • Significant publication record in high-impact journals

  • Collaborative multicenter research and precision medicine orientation

  • Demonstrated leadership in academic and clinical settings

  • Integration of clinical insights with research innovation

Areas for Improvement:

  • Broaden research beyond oncology to explore ENT-related AI/technology

  • Increase international collaborations and visibility at global conferences

  • Expand into clinical trials for therapeutics in HPV+ cancers

🎓 Education: 

Prof. Tamara Braut received her Doctor of Medicine (MD) degree from the University of Rijeka, Croatia, where she also completed her specialization in Otorhinolaryngology. Her academic path was distinguished by an early interest in oncology, molecular pathology, and surgical innovation. She pursued postgraduate training and research with a focus on laryngeal and head and neck cancers. Throughout her education, she was actively involved in academic research, participating in numerous national and international conferences, which sharpened her analytical and investigative skills. She later obtained her PhD with a focus on molecular markers in squamous cell carcinoma. Over the years, she has pursued continuous professional development in precision medicine, oncology biomarkers, and evidence-based surgical practices. Her academic and clinical training has made her a highly competent physician-scientist, well-versed in both patient care and experimental research.

🧑‍🔬 Experience:

Prof. Tamara Braut has over two decades of experience in clinical and academic medicine. She currently serves as the Head of the Department of Otorhinolaryngology and Head and Neck Surgery at the Faculty of Medicine, University of Rijeka. Her career spans clinical work, academic leadership, surgical practice, and scientific research. She has treated complex cases involving laryngeal and head-neck cancers and has led multidisciplinary teams in oncology care. As an educator, she has supervised medical students, residents, and PhD candidates, many of whom now hold academic and clinical positions. Dr. Braut is a prolific researcher, contributing to over 40 peer-reviewed articles, case studies, and reviews. Her leadership in multicenter studies and her role as a principal investigator in several clinical research projects highlight her competence in collaborative and innovative medical research.

🔬 Research Focus:

Prof. Braut’s research focus lies at the intersection of head and neck oncology, molecular diagnostics, and personalized medicine. She has a keen interest in biomarker discovery, especially in HPV-positive head and neck squamous cell carcinomas, and the role of EGFR signaling pathways in cancer progression. Her work includes translational research linking clinical findings with molecular data to improve prognosis, diagnosis, and treatment strategies. She has also explored the impact of hormonal therapies, gene expression markers like Ki-67 and IMP3, and novel imaging and diagnostic tools. In recent years, she has expanded her interest to gastroesophageal reflux disease and its implications in ENT disorders. Her contributions reflect a consistent commitment to advancing precision medicine, long-term patient follow-up, and multimodal treatment outcomes. She continues to integrate research into clinical practice, thereby fostering innovation and improved patient care in the otorhinolaryngology field.

📚 Publications List Top Notes:

  1. 🧬 Laryngeal SCC shows stronger Nectin-4 vs Nectin-2 expression – CIMB (2025)

  2. 🥗 GERD Management: From PPIs to Diet & Lifestyle – Gastrointest. Disord. (2025)

  3. 🔍 Advances in HPV-Positive Head & Neck Cancer Diagnostics – Biomolecules (2024)

  4. 🧪 Biomarkers in HPV+ Head and Neck SCC: Precision Medicine – Diagnostics (2024)

  5. 💉 Testosterone Therapy in Advanced Head & Neck SCC – Crit. Rev. Oncol. Hematol. (2023)

  6. 🏥 Long-Term Care in Laryngeal Cancer: Multicenter Analysis – J Pers. Med (2023)

  7. 📊 5-Year Clinical Course in Laryngeal Tumors – Acta Clin. Croatica (2022)

  8. 🧫 Renal Cell Carcinoma Metastasis to Larynx: Rare Case – Medicina Flum (2021)

  9. 🧠 Posttraumatic Vernet Syndrome without Fracture: Case Study – Medicine (2021)

  10. ⚛️ Nuclear EGFR Expression = Poor Survival in Laryngeal Ca – AIMM (2021)

Conclusion:

Prof. Tamara Braut is highly deserving of the Innovative Research Award. Her work showcases originality, clinical relevance, and scientific depth. With a robust academic and clinical foundation, she continues to push the boundaries in ENT oncology and diagnostics.

 

An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Posted on by sciencefather

Mr. An Dai Tran | Immunology Cellular Interactions | Best Researcher Award

Mr. An Dai Tran, Walailak University, Vietnam

Dr. An Dai Tran is a dedicated medical doctor and emerging public health researcher from Vietnam, currently pursuing a Master’s degree at Walailak University, Thailand. He works at the CDC Dong Thap, focusing on vaccination programs and infectious disease control, including dengue fever, COVID-19, and measles. With several years of hands-on experience in clinical trials and epidemiological research, Dr. Tran has made significant contributions to community health. His published work on vaccination adherence among minority groups in Vietnam has had real-world impact on public health campaigns. Additionally, he has co-developed innovative tools for behavioral science and contributed to machine learning applications in mental health. Collaborating with global institutions such as the University of Queensland and the Pasteur Institute, Dr. Tran’s work reflects a commitment to translational research, public health equity, and data-driven health interventions. His profile is marked by scientific rigor, international collaboration, and service to underserved populations.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Interdisciplinary Research Excellence
    Dr. Tran’s research spans infectious diseases, vaccination behavior, and digital mental health—demonstrating versatility and innovation in addressing modern public health challenges.

  2. Practical and Policy-Relevant Impact
    His work on vaccination adherence in minority communities has real-world implications for national health policy and outreach programs, especially in underserved populations.

  3. Strong Clinical Trial Experience
    He has held critical roles in major vaccine trials (COVID-19 and hand-foot-mouth disease), showing competence in trial design, blinding, and coordination—essential for translational health research.

  4. Collaborative Global Network
    Dr. Tran has established collaborations with renowned institutions such as the University of Queensland and the Pasteur Institute, boosting the credibility and scalability of his research.

  5. Innovation in Mental Health Analytics
    His application of AI and machine learning to post-COVID mental health challenges shows forward-thinking research methodology with future potential.

  6. Published and Cited
    With publications in peer-reviewed journals like Jornal de Pediatria and Journal of Human, Earth, and Future, and a growing citation index, he is building a solid academic foundation.

🛠️ Areas for Improvement:

  1. Broader Indexing and Citations
    While promising, most of his current publications are in emerging or interdisciplinary journals. Publishing in higher-impact, SCI-indexed journals could enhance academic visibility.

  2. Editorial and Peer Review Roles
    Taking on editorial appointments or peer-review duties would strengthen his professional profile and leadership in research.

  3. Mentorship and Teaching Contribution
    Engaging in formal mentorship or academic teaching roles would reflect his potential as a knowledge disseminator and academic influencer.

  4. Expanded Public Health Policy Impact
    Future work that integrates direct contributions to policy development or national programs would further validate his applied research strengths.

🎓 Education:

Dr. An Dai Tran holds a medical degree and is currently completing a Master’s in Public Health at the School of Public Health, Walailak University, Thailand. He was awarded a full scholarship for his postgraduate studies in recognition of his academic excellence and commitment to public health. His education bridges clinical medicine with population-level health sciences, equipping him with multidisciplinary expertise to tackle emerging global health challenges. At Walailak University, Dr. Tran has deepened his knowledge in epidemiology, biostatistics, global health policy, and digital health technologies. His academic training is complemented by a strong foundation in research methodology and ethics, allowing him to conduct high-impact studies and clinical trials. His exposure to both theoretical and practical facets of public health, along with mentorship from international experts, positions him as a future leader in healthcare innovation, with special focus on vaccine-preventable diseases and mental health research in Southeast Asia.

💼 Professional Experience:

Dr. Tran brings valuable on-ground experience through his work at the CDC Dong Thap in Vietnam, where he has led and supported various national vaccination campaigns and infectious disease monitoring systems. He has been actively involved in both the operational and research aspects of public health interventions. His clinical trial roles include coordinating blinded and double-blinded studies on COVID-19 and hand-foot-mouth vaccines. Notably, he served as a research coordinator in large-scale, placebo-controlled trials with rigorous ethical and methodological frameworks. His consultancy record includes four projects in collaboration with governmental and academic institutions, such as the University of Queensland (E-Dengue Project) and the Pasteur Institute (Vietnam-based vaccine research). Dr. Tran’s experience spans public health research, disease surveillance, behavioral analysis, and machine learning for mental health prediction. His combined roles as physician, coordinator, and academic researcher highlight his versatility, responsibility, and drive for impactful health innovations that reach marginalized communities.

🧠 Research Focus:

Dr. Tran’s research lies at the intersection of infectious diseases, vaccination behavior, and digital mental health. His primary interest is understanding the behavioral and sociocultural factors affecting vaccine uptake, particularly among ethnic minority populations. His first-author publication on this topic has already contributed to improved regional strategies for vaccine delivery. Expanding into digital health, Dr. Tran has co-developed psychological assessment tools and applied machine learning to detect mental health issues in post-COVID patients. His work in computational psychiatry includes Reddit-based community sentiment analysis and comparative modeling for long COVID mental health prediction. By merging AI with public health, he aims to enhance early detection and intervention systems. His approach reflects a holistic vision—bridging clinical practice, community outreach, and technology—with a commitment to healthcare equity. Dr. Tran’s research is not only academically sound but also practically applicable, aligning with Sustainable Development Goals (SDGs) for health and well-being.

📚 Publications Top Notes:

  1. 🧬 Parental predictors of childhood vaccination adherence in border areas of Southern Vietnam – Jornal de Pediatria.

  2. 🏃‍♂️ Initial Construction of the Exercise Maintenance Motivation Scale: A Mixed Method Study – Journal of Human, Earth, and Future.

  3. 🤖 An Analysis of Machine Learning for Detecting Depression, Anxiety, and Stress of Recovered COVID-19 Patients – Journal of Human, Earth, and Future.

  4. 🧠 Exploring Mental Stress Expressions in Online Communities: A Subreddit Analysis – Journal of Human, Earth, and Future.

  5. 🧪 Mental health and long COVID status prediction among recovered COVID-19 patients: A comparison of machine learning methods – Journal of Human, Earth, and Future.

🧾 Conclusion:

Dr. An Dai Tran is a highly promising early-career researcher whose interdisciplinary work in public health is both scientifically rigorous and socially impactful. His blend of clinical trial expertise, digital health innovation, and public health behavior research makes him an ideal candidate for the Best Researcher Award. While there is room to grow in areas like journal prestige and academic leadership, his current trajectory, achievements, and commitment to health equity clearly demonstrate award-worthy excellence.

Drosos Kourounis | Microbial Cell Biology | Best Researcher Award

Posted on by sciencefather

Mr. Drosos Kourounis | Microbial Cell Biology | Best Researcher Award

Mr. Drosos Kourounis | Hellenic Pasteur Institute| Greece

Drosos Kourounis is a seasoned biomedical scientist based at the Hellenic Pasteur Institute, Greece. With a strong foundation in molecular biology, his career has spanned from research on parasitic protozoa to developing air purification technologies for public health. His journey began with a BSc and MSc in Biology from the University of Athens, focusing on Leishmania molecular mechanisms. He progressively transitioned into applied research and pharmaceutical quality control, currently serving as the QA/QC Manager at the Hellenic Pasteur Institute. Alongside his scientific duties, he has actively participated in several national seminars and certifications in ISO standards and laboratory quality systems. His contributions to publications, including work on UV-C air disinfection and pathogen bioaerosols, show his commitment to translational science and public health safety. Kourounis’s multidisciplinary skills, research impact, and quality-driven mindset make him a standout figure in the field of biomedical research.

Publication Profile:

Ocrid

✅ Strengths for the Award:

  1. Diverse Research Portfolio: Dr. Kourounis combines basic molecular biology research (e.g., Leishmania donovani protein characterization) with applied public health innovations, such as UVC air filtration devices.

  2. Peer-Reviewed Publications: Multiple first- and co-author publications in reputable journals like International Journal of Molecular Sciences and Clinical Research and Reviews highlight his consistent research productivity.

  3. Quality & Regulatory Expertise: His role as QA/QC Manager and extensive ISO training show strong competence in scientific quality assurance, a rare but highly valuable skill in biomedical research.

  4. Public Health Impact: His work on airborne microbial bioaerosols reduction is highly relevant to healthcare, particularly in post-pandemic times.

  5. Academic Excellence: Achieved a 10/10 thesis grade for MSc research and has shown continued academic engagement and scientific rigor.

🛠️ Areas for Improvement:

  1. More International Collaborations: While his current network is strong locally, expanding his collaborations globally would increase visibility and cross-disciplinary impact.

  2. Greater Research Specialization: A more narrowly defined focus could strengthen academic identity and make his profile stand out further among specialized researchers.

  3. Funding and Grants: No mention of securing independent grants or fellowships, which are key indicators of research independence and innovation leadership.

🎓 Education:

Drosos Kourounis holds both a Bachelor of Science (2013) and Master of Science (2017) in Biology from the University of Athens, Greece. His MSc focused on molecular parasitology, specifically the cloning and characterization of a secreted nexin-like protein from Leishmania donovani, which earned him a perfect thesis score (10/10). Complementing his formal education, Kourounis has pursued multiple professional certifications in laboratory quality systems, including ISO 17025 and ISO/IEC 17025 accreditation seminars, conducted by institutions like TUV HELLAS and HellasLab. In 2021, he also completed certified training in laboratory animal science at the Hellenic Pasteur Institute, showing his commitment to ethical and regulatory compliance in biomedical research. His training portfolio demonstrates a keen interest in continuous education and the application of scientific standards in both academic and industrial environments. His educational journey reflects a balance between foundational science and regulatory excellence.

💼 Experience:

Drosos Kourounis has over 7 years of cumulative experience in biomedical research and quality control. He is currently the Quality Assurance and Quality Control Manager at the Hellenic Pasteur Institute (since January 2023), where he oversees pharmaceutical QC processes. Previously, he served as Senior QC Analyst (2022) and QC Analyst (2019–2021) at the same institution. His earlier roles include Scientific Collaborator at MEGALAB S.A. and Research Assistant at the Intracellular Parasitism group in the Hellenic Pasteur Institute. During his research tenure, he contributed to molecular studies on Leishmania donovani and the development of innovative air disinfection systems. He is recognized for his dual role as a scientist and regulatory professional, combining rigorous lab work with compliance to ISO standards. His professional trajectory showcases a steady progression toward leadership in quality control, along with consistent scientific contributions to public health and infectious disease research.

🔬 Research Focus:

Drosos Kourounis’s research lies at the intersection of molecular parasitology, bioaerosol control, and public health technology. His academic work began with the cloning and analysis of Leishmania donovani proteins, contributing to the understanding of host-parasite interactions. Transitioning from pure biology, his focus expanded to the development of innovative air disinfection technologies, including UV-C integrated filtration systems aimed at mitigating microbial exposure in clinical and public environments. This shift highlights a commitment to translational research that addresses real-world problems, such as hospital-acquired infections and airborne pathogen control. His contributions are evident in publications across molecular sciences and applied electromagnetics. Moreover, he incorporates quality assurance principles into his scientific work, ensuring research reproducibility and compliance with international standards.

📚 Publication Top Notes: 

  • 🧬 Cloning and molecular characterization of the secreted nexin-like protein LdPIBPnex, from the protozoon Leishmania donovani

  • 🌬️ Substantial Reduction of Airborne Microbial Bioaerosols by Using a Novel Combination of Air Filtration and UV Irradiation Technology in Areas of Public Interest

  • 🧫 Characterization of the First Secreted Sorting Nexin Identified in the Leishmania Protists

  • 🏥 A Study on the Reduction of Airborne Microbial Bioaerosols at Indoor Air of Hospital’s Intensive Care Unit by Using Novel Air Filtration and UV Irradiation Technology

  • 😷 Design and Analysis of a Protecting Breathing Device (VITER) Disinfecting Air with an Integrated UVC Radiation Mechanism

 

🧾 Conclusion:

Dr. Drosos Kourounis demonstrates exceptional dedication to biomedical research, quality assurance, and innovation in public health safety. His dual focus on molecular parasitology and technological solutions for microbial air control showcases both scientific depth and societal impact. With a growing publication record and leadership role in a premier research institute, he is well-positioned for recognition. Enhancing global visibility and grant acquisition could elevate his profile further. Overall, he is highly suitable and deserving of serious consideration for the Best Researcher Award.